Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mybl2
|
ENSMUSG00000017861.5 | myeloblastosis oncogene-like 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_163054168_163055159 | Mybl2 | 24 | 0.963532 | 0.82 | 3.5e-14 | Click! |
chr2_163055332_163055489 | Mybl2 | 723 | 0.554802 | 0.65 | 7.1e-08 | Click! |
chr2_163055606_163055757 | Mybl2 | 994 | 0.423375 | 0.63 | 2.2e-07 | Click! |
chr2_163056790_163056941 | Mybl2 | 2178 | 0.207164 | 0.43 | 9.1e-04 | Click! |
chr2_163071706_163071857 | Mybl2 | 2964 | 0.159936 | 0.42 | 1.3e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_78072843_78073236 | 28.85 |
Mir144 |
microRNA 144 |
34 |
0.49 |
chr16_38371774_38372058 | 19.68 |
Popdc2 |
popeye domain containing 2 |
82 |
0.95 |
chr10_54042474_54042667 | 18.72 |
Gm47917 |
predicted gene, 47917 |
21241 |
0.18 |
chr7_110920476_110920635 | 17.99 |
Mrvi1 |
MRV integration site 1 |
3148 |
0.23 |
chr6_146611446_146611715 | 17.56 |
Tm7sf3 |
transmembrane 7 superfamily member 3 |
22918 |
0.11 |
chr9_64533581_64533938 | 17.46 |
Megf11 |
multiple EGF-like-domains 11 |
13140 |
0.25 |
chr2_170151630_170151806 | 17.13 |
Zfp217 |
zinc finger protein 217 |
3615 |
0.34 |
chr1_136347174_136347468 | 16.59 |
Camsap2 |
calmodulin regulated spectrin-associated protein family, member 2 |
1217 |
0.44 |
chr1_168287679_168288893 | 15.75 |
Gm37524 |
predicted gene, 37524 |
49385 |
0.16 |
chr5_137570789_137570985 | 15.62 |
Tfr2 |
transferrin receptor 2 |
82 |
0.91 |
chr2_131454418_131454583 | 14.61 |
Gm14304 |
predicted gene 14304 |
140 |
0.95 |
chr9_71166081_71166377 | 14.48 |
Aqp9 |
aquaporin 9 |
1007 |
0.5 |
chr14_57692610_57692779 | 14.26 |
Gm26440 |
predicted gene, 26440 |
5115 |
0.14 |
chr19_36451868_36452309 | 14.25 |
F530104D19Rik |
RIKEN cDNA F530104D19 gene |
931 |
0.55 |
chr4_59234561_59234731 | 13.84 |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
21990 |
0.16 |
chr11_87749523_87749886 | 13.54 |
Mir142hg |
Mir142 host gene (non-protein coding) |
5873 |
0.09 |
chr16_76314408_76314575 | 13.04 |
Nrip1 |
nuclear receptor interacting protein 1 |
9167 |
0.25 |
chr11_24130479_24130638 | 12.79 |
Bcl11a |
B cell CLL/lymphoma 11A (zinc finger protein) |
11821 |
0.15 |
chr15_5459219_5459378 | 12.71 |
Gm46496 |
predicted gene, 46496 |
4877 |
0.26 |
chr13_83382718_83382891 | 12.62 |
Mef2c |
myocyte enhancer factor 2C |
121230 |
0.06 |
chr16_49799705_49799872 | 12.41 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
745 |
0.51 |
chr17_83684505_83684810 | 12.40 |
Mta3 |
metastasis associated 3 |
21506 |
0.21 |
chr2_103957767_103958059 | 12.20 |
Lmo2 |
LIM domain only 2 |
73 |
0.96 |
chr12_88984058_88984248 | 12.15 |
Nrxn3 |
neurexin III |
30754 |
0.23 |
chr11_85799924_85800126 | 12.01 |
Bcas3 |
breast carcinoma amplified sequence 3 |
1796 |
0.24 |
chr1_118417525_118417692 | 11.98 |
Clasp1 |
CLIP associating protein 1 |
1952 |
0.28 |
chr9_108338578_108339700 | 11.93 |
Gpx1 |
glutathione peroxidase 1 |
85 |
0.89 |
chr4_154929190_154929525 | 11.80 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
794 |
0.51 |
chr9_115166107_115166297 | 11.75 |
Gm4665 |
predicted gene 4665 |
19856 |
0.15 |
chr2_153495771_153496762 | 11.61 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
3476 |
0.22 |
chr5_37457238_37457504 | 11.47 |
Evc2 |
EvC ciliary complex subunit 2 |
41512 |
0.16 |
chr12_4873296_4873469 | 11.47 |
Mfsd2b |
major facilitator superfamily domain containing 2B |
963 |
0.43 |
chr8_85396188_85396364 | 11.46 |
Mylk3 |
myosin light chain kinase 3 |
9931 |
0.13 |
chr2_29035787_29036046 | 11.40 |
Cfap77 |
cilia and flagella associated protein 77 |
3444 |
0.21 |
chr13_112747894_112748068 | 11.38 |
Slc38a9 |
solute carrier family 38, member 9 |
12371 |
0.15 |
chr2_18997988_18998869 | 11.23 |
4930426L09Rik |
RIKEN cDNA 4930426L09 gene |
85 |
0.78 |
chr17_34210626_34210847 | 11.23 |
Tap2 |
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
3030 |
0.09 |
chr5_148935852_148936151 | 11.20 |
Katnal1 |
katanin p60 subunit A-like 1 |
6681 |
0.1 |
chr1_37478554_37478868 | 10.99 |
4930594C11Rik |
RIKEN cDNA 4930594C11 gene |
9894 |
0.14 |
chr13_111940877_111941182 | 10.96 |
Gm15322 |
predicted gene 15322 |
50437 |
0.1 |
chr9_48338868_48339031 | 10.94 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
1885 |
0.36 |
chr2_105769867_105770156 | 10.76 |
Elp4 |
elongator acetyltransferase complex subunit 4 |
44311 |
0.13 |
chr9_65554974_65555491 | 10.74 |
Plekho2 |
pleckstrin homology domain containing, family O member 2 |
6932 |
0.14 |
chr7_115550576_115550741 | 10.71 |
Sox6 |
SRY (sex determining region Y)-box 6 |
47238 |
0.19 |
chr3_96458985_96459162 | 10.67 |
Gm10685 |
predicted gene 10685 |
864 |
0.24 |
chr1_179961389_179961657 | 10.66 |
Cdc42bpa |
CDC42 binding protein kinase alpha |
413 |
0.86 |
chr14_75178641_75178799 | 10.64 |
Lcp1 |
lymphocyte cytosolic protein 1 |
2512 |
0.23 |
chr9_43116070_43116441 | 10.59 |
Tlcd5 |
TLC domain containing 5 |
278 |
0.9 |
chr3_60602746_60603521 | 10.58 |
Mbnl1 |
muscleblind like splicing factor 1 |
405 |
0.79 |
chr13_23756786_23757801 | 10.45 |
H4c2 |
H4 clustered histone 2 |
280 |
0.44 |
chr10_89423193_89423348 | 10.45 |
Gas2l3 |
growth arrest-specific 2 like 3 |
10572 |
0.25 |
chr1_77281437_77282151 | 10.37 |
Epha4 |
Eph receptor A4 |
95813 |
0.08 |
chrX_104544037_104544198 | 10.34 |
Uprt |
uracil phosphoribosyltransferase |
61299 |
0.11 |
chr11_87755415_87755594 | 10.28 |
Mir142hg |
Mir142 host gene (non-protein coding) |
73 |
0.91 |
chr7_103861338_103861749 | 10.23 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
8327 |
0.06 |
chr6_33055731_33056078 | 10.13 |
Chchd3 |
coiled-coil-helix-coiled-coil-helix domain containing 3 |
4313 |
0.2 |
chr4_135985229_135985393 | 10.13 |
Pithd1 |
PITH (C-terminal proteasome-interacting domain of thioredoxin-like) domain containing 1 |
627 |
0.51 |
chr9_66193900_66194051 | 10.08 |
Dapk2 |
death-associated protein kinase 2 |
26772 |
0.17 |
chr2_91950295_91950718 | 10.03 |
Dgkz |
diacylglycerol kinase zeta |
79 |
0.95 |
chr13_21170243_21170544 | 10.01 |
Trim27 |
tripartite motif-containing 27 |
9052 |
0.13 |
chr5_36621203_36621401 | 10.01 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
47 |
0.96 |
chr16_38372070_38372249 | 10.00 |
Popdc2 |
popeye domain containing 2 |
161 |
0.93 |
chr4_125037620_125037809 | 10.00 |
Gnl2 |
guanine nucleotide binding protein-like 2 (nucleolar) |
3244 |
0.15 |
chr6_5155101_5155310 | 9.97 |
Pon1 |
paraoxonase 1 |
38558 |
0.14 |
chr6_28622064_28622236 | 9.95 |
Gm37978 |
predicted gene, 37978 |
54078 |
0.11 |
chr7_111004551_111004720 | 9.85 |
Mrvi1 |
MRV integration site 1 |
22174 |
0.15 |
chr5_34924526_34924867 | 9.77 |
Msantd1 |
Myb/SANT-like DNA-binding domain containing 1 |
7157 |
0.18 |
chr8_67570409_67570727 | 9.77 |
Gm36247 |
predicted gene, 36247 |
14622 |
0.18 |
chr17_12378113_12378280 | 9.77 |
Plg |
plasminogen |
412 |
0.81 |
chr9_96259872_96260060 | 9.77 |
Tfdp2 |
transcription factor Dp 2 |
681 |
0.67 |
chr7_37092786_37092962 | 9.75 |
Gm28078 |
predicted gene 28078 |
35818 |
0.17 |
chr1_131136268_131136546 | 9.73 |
Dyrk3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
1838 |
0.26 |
chr7_80166850_80167041 | 9.61 |
Gm45202 |
predicted gene 45202 |
11776 |
0.11 |
chr2_131518798_131519083 | 9.61 |
Smox |
spermine oxidase |
1246 |
0.45 |
chr15_78571727_78571930 | 9.58 |
Rac2 |
Rac family small GTPase 2 |
953 |
0.39 |
chr10_83945524_83945740 | 9.38 |
Gm47247 |
predicted gene, 47247 |
43780 |
0.15 |
chr3_84478313_84478477 | 9.38 |
Fhdc1 |
FH2 domain containing 1 |
587 |
0.79 |
chr2_102366116_102366274 | 9.35 |
Trim44 |
tripartite motif-containing 44 |
34062 |
0.18 |
chr11_65774381_65774542 | 9.35 |
Map2k4 |
mitogen-activated protein kinase kinase 4 |
13824 |
0.2 |
chr10_93890636_93890822 | 9.33 |
Metap2 |
methionine aminopeptidase 2 |
400 |
0.78 |
chr7_120861312_120861627 | 9.17 |
Eef2k |
eukaryotic elongation factor-2 kinase |
10280 |
0.13 |
chr18_64538976_64539165 | 9.14 |
Atp8b1 |
ATPase, class I, type 8B, member 1 |
16130 |
0.15 |
chr6_57746178_57746350 | 9.11 |
Lancl2 |
LanC (bacterial lantibiotic synthetase component C)-like 2 |
43177 |
0.09 |
chr3_95517252_95517598 | 9.10 |
Ctss |
cathepsin S |
9361 |
0.1 |
chr3_145508692_145508884 | 9.04 |
Col24a1 |
collagen, type XXIV, alpha 1 |
6580 |
0.24 |
chr15_62221087_62221407 | 9.03 |
Pvt1 |
Pvt1 oncogene |
1356 |
0.44 |
chr7_106652317_106652613 | 9.02 |
Olfr693 |
olfactory receptor 693 |
26020 |
0.11 |
chr4_120844524_120844694 | 8.95 |
Gm23936 |
predicted gene, 23936 |
7121 |
0.12 |
chr8_23053611_23053959 | 8.94 |
Ank1 |
ankyrin 1, erythroid |
4474 |
0.2 |
chr10_108582876_108583037 | 8.94 |
Syt1 |
synaptotagmin I |
54008 |
0.14 |
chr4_32170819_32170999 | 8.92 |
Gm11928 |
predicted gene 11928 |
21123 |
0.18 |
chr13_109680381_109680587 | 8.89 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
5672 |
0.35 |
chr9_43242586_43242750 | 8.88 |
D630033O11Rik |
RIKEN cDNA D630033O11 gene |
931 |
0.49 |
chr1_59492529_59492732 | 8.88 |
Gm26813 |
predicted gene, 26813 |
25 |
0.97 |
chr1_165356506_165356657 | 8.86 |
Dcaf6 |
DDB1 and CUL4 associated factor 6 |
4583 |
0.18 |
chr16_90213465_90213772 | 8.86 |
Sod1 |
superoxide dismutase 1, soluble |
7136 |
0.16 |
chr19_32523822_32524155 | 8.80 |
Gm36419 |
predicted gene, 36419 |
19360 |
0.15 |
chr7_90080233_90080388 | 8.79 |
Gm5341 |
predicted pseudogene 5341 |
27658 |
0.1 |
chr5_150578532_150578834 | 8.79 |
N4bp2l1 |
NEDD4 binding protein 2-like 1 |
1692 |
0.18 |
chr10_42537669_42537945 | 8.66 |
Nr2e1 |
nuclear receptor subfamily 2, group E, member 1 |
31021 |
0.14 |
chr17_84776411_84776576 | 8.65 |
Lrpprc |
leucine-rich PPR-motif containing |
1050 |
0.49 |
chr9_122103667_122103820 | 8.63 |
Snrk |
SNF related kinase |
13523 |
0.11 |
chr15_53206002_53206288 | 8.56 |
Ext1 |
exostosin glycosyltransferase 1 |
9890 |
0.32 |
chr5_103741831_103742104 | 8.56 |
Aff1 |
AF4/FMR2 family, member 1 |
12195 |
0.2 |
chr17_83956741_83957102 | 8.54 |
Gm35229 |
predicted gene, 35229 |
673 |
0.54 |
chr15_27497025_27497208 | 8.54 |
B230362B09Rik |
RIKEN cDNA B230362B09 gene |
6796 |
0.17 |
chr4_130715186_130715488 | 8.50 |
Snord85 |
small nucleolar RNA, C/D box 85 |
34297 |
0.11 |
chr18_84091015_84091219 | 8.46 |
Zadh2 |
zinc binding alcohol dehydrogenase, domain containing 2 |
2446 |
0.23 |
chr5_137085033_137085367 | 8.45 |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
12932 |
0.11 |
chr6_92274056_92274227 | 8.44 |
Gm44803 |
predicted gene 44803 |
2569 |
0.24 |
chr10_77091592_77091784 | 8.41 |
Col18a1 |
collagen, type XVIII, alpha 1 |
2260 |
0.27 |
chr11_72689444_72689604 | 8.34 |
Ankfy1 |
ankyrin repeat and FYVE domain containing 1 |
482 |
0.8 |
chr5_147489307_147489518 | 8.33 |
Pan3 |
PAN3 poly(A) specific ribonuclease subunit |
28090 |
0.12 |
chr2_173056725_173057347 | 8.25 |
Gm14453 |
predicted gene 14453 |
22456 |
0.12 |
chr1_153021269_153021607 | 8.23 |
Nmnat2 |
nicotinamide nucleotide adenylyltransferase 2 |
11936 |
0.2 |
chr11_4543369_4543542 | 8.18 |
Mtmr3 |
myotubularin related protein 3 |
2813 |
0.24 |
chr9_50856310_50857724 | 8.17 |
Ppp2r1b |
protein phosphatase 2, regulatory subunit A, beta |
38 |
0.97 |
chr15_64310876_64311084 | 8.16 |
Asap1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain1 |
709 |
0.66 |
chr14_29996026_29996395 | 8.16 |
Il17rb |
interleukin 17 receptor B |
2249 |
0.18 |
chr6_121111643_121111794 | 8.15 |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
1624 |
0.32 |
chr5_137290517_137290668 | 8.13 |
Ache |
acetylcholinesterase |
1345 |
0.18 |
chr1_133895698_133895860 | 8.13 |
Optc |
opticin |
5548 |
0.15 |
chrX_144318156_144319018 | 8.12 |
Alg13 |
asparagine-linked glycosylation 13 |
564 |
0.68 |
chr10_80421820_80422012 | 8.09 |
Tcf3 |
transcription factor 3 |
56 |
0.94 |
chr2_131454120_131454271 | 8.07 |
Gm14304 |
predicted gene 14304 |
445 |
0.8 |
chr2_93456201_93456461 | 7.95 |
Gm10804 |
predicted gene 10804 |
3510 |
0.2 |
chr10_67296584_67296742 | 7.93 |
Gm49454 |
predicted gene, 49454 |
743 |
0.63 |
chr6_116350044_116350568 | 7.87 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
79 |
0.95 |
chr6_127321540_127321865 | 7.86 |
Gm43636 |
predicted gene 43636 |
3361 |
0.16 |
chr9_64938896_64939082 | 7.84 |
Slc24a1 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 |
12618 |
0.14 |
chr4_139336903_139337100 | 7.80 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
179 |
0.83 |
chr8_122329580_122330425 | 7.78 |
Zfpm1 |
zinc finger protein, multitype 1 |
3696 |
0.15 |
chr5_97300564_97300733 | 7.78 |
Gm33969 |
predicted gene, 33969 |
25256 |
0.17 |
chr10_62215401_62215586 | 7.77 |
Tspan15 |
tetraspanin 15 |
13716 |
0.15 |
chr11_107092787_107092963 | 7.74 |
Bptf |
bromodomain PHD finger transcription factor |
25670 |
0.14 |
chr4_150649401_150649570 | 7.74 |
Slc45a1 |
solute carrier family 45, member 1 |
2612 |
0.27 |
chr11_86593057_86593325 | 7.72 |
Vmp1 |
vacuole membrane protein 1 |
6197 |
0.16 |
chr10_117105122_117105332 | 7.69 |
Frs2 |
fibroblast growth factor receptor substrate 2 |
25619 |
0.12 |
chr8_111509409_111509600 | 7.68 |
Wdr59 |
WD repeat domain 59 |
12483 |
0.17 |
chr4_151730005_151730352 | 7.66 |
Camta1 |
calmodulin binding transcription activator 1 |
131472 |
0.05 |
chr17_71238518_71238794 | 7.65 |
Lpin2 |
lipin 2 |
6 |
0.97 |
chr13_35756792_35756964 | 7.63 |
Cdyl |
chromodomain protein, Y chromosome-like |
5934 |
0.19 |
chr1_133826080_133826268 | 7.62 |
Gm10537 |
predicted gene 10537 |
3354 |
0.18 |
chr5_115884541_115884726 | 7.60 |
Cit |
citron |
1785 |
0.3 |
chr18_68039386_68039559 | 7.56 |
Gm41764 |
predicted gene, 41764 |
78902 |
0.09 |
chr2_19011550_19011844 | 7.55 |
4930426L09Rik |
RIKEN cDNA 4930426L09 gene |
13354 |
0.2 |
chr5_137116456_137116638 | 7.55 |
Trim56 |
tripartite motif-containing 56 |
338 |
0.8 |
chr1_167802317_167803268 | 7.53 |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
113235 |
0.07 |
chr13_51979366_51979590 | 7.53 |
Gm26651 |
predicted gene, 26651 |
6264 |
0.25 |
chr9_43240292_43240713 | 7.52 |
Oaf |
out at first homolog |
591 |
0.68 |
chr8_84900828_84901106 | 7.51 |
Klf1 |
Kruppel-like factor 1 (erythroid) |
961 |
0.28 |
chr3_67564859_67565022 | 7.50 |
4930402C01Rik |
RIKEN cDNA 4930402C01 gene |
7881 |
0.12 |
chr8_86708159_86708313 | 7.49 |
Gm22305 |
predicted gene, 22305 |
36893 |
0.11 |
chr15_100391831_100391983 | 7.49 |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
11336 |
0.11 |
chr10_95290022_95290265 | 7.45 |
Gm48880 |
predicted gene, 48880 |
24710 |
0.13 |
chr5_75624376_75624665 | 7.41 |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
12595 |
0.22 |
chr12_75724761_75724933 | 7.40 |
Sgpp1 |
sphingosine-1-phosphate phosphatase 1 |
10849 |
0.22 |
chr5_57782194_57782347 | 7.39 |
Gm42481 |
predicted gene 42481 |
3397 |
0.17 |
chr19_5726991_5727271 | 7.31 |
Gm16538 |
predicted gene 16538 |
75 |
0.87 |
chr8_10990579_10990754 | 7.31 |
9530052E02Rik |
RIKEN cDNA 9530052E02 gene |
17184 |
0.11 |
chr7_135581161_135581493 | 7.26 |
Ptpre |
protein tyrosine phosphatase, receptor type, E |
12061 |
0.17 |
chr17_63979339_63979498 | 7.23 |
Fer |
fer (fms/fps related) protein kinase |
41446 |
0.2 |
chr16_56071315_56071566 | 7.22 |
Gm24047 |
predicted gene, 24047 |
877 |
0.45 |
chr16_93744024_93744391 | 7.19 |
Dop1b |
DOP1 leucine zipper like protein B |
14108 |
0.16 |
chr1_151095769_151095964 | 7.19 |
Gm19087 |
predicted gene, 19087 |
12049 |
0.13 |
chr6_72384008_72384159 | 7.15 |
Vamp5 |
vesicle-associated membrane protein 5 |
3615 |
0.12 |
chr4_42879962_42880119 | 7.10 |
Fam205c |
family with sequence similarity 205, member C |
5806 |
0.14 |
chr7_142091954_142092194 | 7.09 |
Dusp8 |
dual specificity phosphatase 8 |
3198 |
0.1 |
chr9_123468829_123469039 | 7.08 |
Limd1 |
LIM domains containing 1 |
9772 |
0.18 |
chr16_56801807_56801992 | 7.07 |
Adgrg7 |
adhesion G protein-coupled receptor G7 |
6044 |
0.19 |
chr2_154765762_154765945 | 7.05 |
Gm14214 |
predicted gene 14214 |
4079 |
0.16 |
chr11_11728119_11728509 | 7.05 |
Gm12000 |
predicted gene 12000 |
31875 |
0.14 |
chr17_33432108_33432282 | 7.05 |
Actl9 |
actin-like 9 |
701 |
0.63 |
chr14_47533459_47534172 | 7.05 |
Fbxo34 |
F-box protein 34 |
7736 |
0.12 |
chr4_154161520_154161681 | 7.04 |
Tprgl |
transformation related protein 63 regulated like |
934 |
0.43 |
chrX_71545348_71545518 | 7.02 |
Hmgb3 |
high mobility group box 3 |
10485 |
0.17 |
chrX_150564540_150564715 | 7.02 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
1763 |
0.29 |
chr3_96451263_96451652 | 7.01 |
BC107364 |
cDNA sequence BC107364 |
849 |
0.24 |
chr1_93046199_93046474 | 7.00 |
Kif1a |
kinesin family member 1A |
7966 |
0.14 |
chr13_57577621_57577808 | 6.99 |
Gm48176 |
predicted gene, 48176 |
301036 |
0.01 |
chr17_25086830_25087001 | 6.97 |
Tmem204 |
transmembrane protein 204 |
3324 |
0.13 |
chr11_98729108_98729262 | 6.95 |
Med24 |
mediator complex subunit 24 |
182 |
0.89 |
chr18_21283772_21283949 | 6.95 |
Garem1 |
GRB2 associated regulator of MAPK1 subtype 1 |
16263 |
0.17 |
chrX_129448613_129448901 | 6.95 |
Gm14986 |
predicted gene 14986 |
69769 |
0.12 |
chr9_90259841_90260078 | 6.93 |
Tbc1d2b |
TBC1 domain family, member 2B |
4032 |
0.2 |
chr4_89510011_89510342 | 6.92 |
Gm12608 |
predicted gene 12608 |
65532 |
0.11 |
chr10_62327543_62328005 | 6.91 |
Hk1 |
hexokinase 1 |
7 |
0.97 |
chr13_113861430_113861607 | 6.89 |
Arl15 |
ADP-ribosylation factor-like 15 |
66896 |
0.09 |
chr2_49730225_49730511 | 6.88 |
Kif5c |
kinesin family member 5C |
2243 |
0.36 |
chr14_32168937_32169216 | 6.88 |
Ncoa4 |
nuclear receptor coactivator 4 |
1669 |
0.23 |
chr12_83072665_83072920 | 6.87 |
Rgs6 |
regulator of G-protein signaling 6 |
25802 |
0.15 |
chr9_111056836_111057083 | 6.87 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
287 |
0.82 |
chr5_96950219_96950386 | 6.86 |
Gm43144 |
predicted gene 43144 |
10005 |
0.11 |
chr10_77298763_77298927 | 6.85 |
Pofut2 |
protein O-fucosyltransferase 2 |
31928 |
0.14 |
chr5_147893079_147893535 | 6.84 |
Slc46a3 |
solute carrier family 46, member 3 |
1508 |
0.36 |
chr8_40659182_40659366 | 6.81 |
Adam24 |
a disintegrin and metallopeptidase domain 24 (testase 1) |
15803 |
0.13 |
chr17_84154262_84154638 | 6.79 |
Gm19696 |
predicted gene, 19696 |
1976 |
0.29 |
chr2_126151699_126152275 | 6.79 |
Fam227b |
family with sequence similarity 227, member B |
3 |
0.66 |
chr15_73635575_73635901 | 6.77 |
Slc45a4 |
solute carrier family 45, member 4 |
9607 |
0.17 |
chr13_100833116_100833889 | 6.76 |
Slc30a5 |
solute carrier family 30 (zinc transporter), member 5 |
75 |
0.96 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.9 | 26.8 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
6.7 | 26.9 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
6.0 | 6.0 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
3.8 | 11.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.8 | 11.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
3.5 | 14.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
3.4 | 10.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
3.4 | 10.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
3.1 | 9.3 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
3.0 | 9.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
2.6 | 13.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
2.6 | 10.4 | GO:0050904 | diapedesis(GO:0050904) |
2.6 | 20.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
2.5 | 12.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.5 | 7.6 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
2.5 | 7.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
2.4 | 12.2 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
2.4 | 4.8 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.4 | 7.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
2.3 | 11.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
2.3 | 9.3 | GO:0008228 | opsonization(GO:0008228) |
2.3 | 9.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
2.3 | 6.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.2 | 11.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
2.2 | 6.6 | GO:0032439 | endosome localization(GO:0032439) |
2.1 | 6.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.0 | 6.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
2.0 | 12.1 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
2.0 | 10.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
2.0 | 5.9 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.9 | 36.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
1.9 | 5.7 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
1.9 | 3.8 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.8 | 7.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.8 | 3.6 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.8 | 7.2 | GO:0070836 | caveola assembly(GO:0070836) |
1.8 | 7.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.7 | 13.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
1.7 | 6.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.7 | 3.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.7 | 6.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.7 | 6.7 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
1.7 | 5.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.7 | 1.7 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
1.7 | 6.6 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
1.6 | 9.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.6 | 4.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.6 | 8.1 | GO:0097459 | iron ion import into cell(GO:0097459) |
1.6 | 4.8 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.6 | 6.4 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.6 | 4.8 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.6 | 9.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.6 | 3.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.6 | 4.7 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
1.6 | 4.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.6 | 3.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
1.6 | 15.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.5 | 3.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.5 | 4.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.5 | 7.6 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.5 | 4.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.5 | 4.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.5 | 4.5 | GO:0097286 | iron ion import(GO:0097286) |
1.5 | 4.5 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
1.5 | 4.5 | GO:0045472 | response to ether(GO:0045472) |
1.5 | 12.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.5 | 4.5 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.5 | 5.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.5 | 13.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.4 | 7.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.4 | 5.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.4 | 2.9 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.4 | 7.1 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.4 | 2.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.4 | 8.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
1.4 | 4.2 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
1.4 | 5.6 | GO:0048478 | replication fork protection(GO:0048478) |
1.4 | 9.8 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.4 | 2.8 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
1.4 | 8.3 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.4 | 9.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.4 | 5.5 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.4 | 4.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.4 | 8.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.4 | 5.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.4 | 5.4 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
1.4 | 5.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
1.4 | 4.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.3 | 2.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.3 | 4.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.3 | 10.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.3 | 5.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.3 | 4.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.3 | 4.0 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.3 | 4.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.3 | 1.3 | GO:0009136 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
1.3 | 6.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.3 | 3.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.3 | 3.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.3 | 6.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.3 | 3.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.3 | 6.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.3 | 3.9 | GO:0000087 | mitotic M phase(GO:0000087) |
1.3 | 7.6 | GO:0051013 | microtubule severing(GO:0051013) |
1.3 | 6.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.3 | 3.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.3 | 5.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.3 | 5.0 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
1.2 | 3.7 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.2 | 6.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.2 | 2.5 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
1.2 | 3.7 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.2 | 4.9 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
1.2 | 3.7 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.2 | 3.7 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.2 | 1.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
1.2 | 7.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.2 | 2.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.2 | 2.4 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.2 | 10.8 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
1.2 | 6.0 | GO:0009642 | response to light intensity(GO:0009642) |
1.2 | 3.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.2 | 10.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.2 | 4.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.2 | 3.5 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
1.2 | 3.5 | GO:0030576 | Cajal body organization(GO:0030576) |
1.2 | 10.5 | GO:0007097 | nuclear migration(GO:0007097) |
1.2 | 5.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.1 | 3.4 | GO:0051168 | nuclear export(GO:0051168) |
1.1 | 4.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.1 | 4.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.1 | 3.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.1 | 3.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
1.1 | 5.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.1 | 32.0 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
1.1 | 8.8 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.1 | 4.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.1 | 3.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.1 | 2.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.1 | 1.1 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
1.1 | 3.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.1 | 1.1 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
1.0 | 3.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.0 | 3.1 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
1.0 | 3.1 | GO:0030242 | pexophagy(GO:0030242) |
1.0 | 5.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
1.0 | 4.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.0 | 3.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
1.0 | 4.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
1.0 | 2.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.0 | 4.0 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
1.0 | 6.0 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
1.0 | 5.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
1.0 | 3.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.0 | 1.0 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
1.0 | 4.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.0 | 3.0 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.0 | 14.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.0 | 3.0 | GO:0034214 | protein hexamerization(GO:0034214) |
1.0 | 2.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.0 | 1.0 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
1.0 | 3.0 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.0 | 7.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.0 | 2.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
1.0 | 3.9 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.0 | 2.9 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
1.0 | 2.9 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
1.0 | 1.9 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
1.0 | 9.7 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
1.0 | 19.3 | GO:0048821 | erythrocyte development(GO:0048821) |
1.0 | 2.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.0 | 1.9 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.0 | 1.0 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.0 | 2.9 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.0 | 8.6 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.9 | 1.9 | GO:0036258 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
0.9 | 2.8 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.9 | 9.3 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.9 | 7.4 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.9 | 2.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.9 | 7.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.9 | 6.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.9 | 2.7 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.9 | 9.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.9 | 2.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.9 | 4.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.9 | 5.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.9 | 3.6 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.9 | 3.5 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.9 | 2.7 | GO:0061511 | centriole elongation(GO:0061511) |
0.9 | 6.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.9 | 1.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.9 | 1.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.9 | 8.8 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.9 | 3.5 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.9 | 3.5 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
0.9 | 3.5 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.9 | 2.6 | GO:0008050 | female courtship behavior(GO:0008050) |
0.9 | 8.7 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.9 | 2.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.9 | 1.7 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.9 | 13.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.9 | 5.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.9 | 11.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.9 | 2.6 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.9 | 2.6 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.8 | 0.8 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.8 | 2.5 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.8 | 3.4 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.8 | 0.8 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.8 | 3.3 | GO:0045006 | DNA deamination(GO:0045006) |
0.8 | 5.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.8 | 3.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.8 | 5.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.8 | 2.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.8 | 3.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.8 | 2.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.8 | 18.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.8 | 0.8 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.8 | 2.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.8 | 3.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.8 | 5.7 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.8 | 2.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.8 | 3.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.8 | 0.8 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.8 | 3.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.8 | 4.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.8 | 1.6 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.8 | 6.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.8 | 4.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 8.8 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.8 | 4.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.8 | 2.4 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.8 | 4.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.8 | 7.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.8 | 7.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.8 | 0.8 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.8 | 1.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.8 | 7.0 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.8 | 6.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.8 | 4.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.8 | 3.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.8 | 3.9 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.8 | 3.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.8 | 3.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.8 | 4.6 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.8 | 2.3 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.8 | 3.8 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.8 | 1.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.8 | 3.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.8 | 3.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.8 | 2.3 | GO:0061010 | gall bladder development(GO:0061010) |
0.8 | 4.6 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.8 | 4.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.8 | 2.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.8 | 3.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.8 | 1.5 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.7 | 3.0 | GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.7 | 8.2 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.7 | 2.2 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.7 | 3.0 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.7 | 6.0 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.7 | 1.5 | GO:0019042 | viral latency(GO:0019042) |
0.7 | 3.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.7 | 0.7 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.7 | 2.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.7 | 4.4 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.7 | 4.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.7 | 1.5 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.7 | 0.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.7 | 1.5 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.7 | 2.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.7 | 2.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.7 | 2.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.7 | 1.4 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.7 | 8.5 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.7 | 0.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.7 | 2.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.7 | 2.1 | GO:0072611 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.7 | 8.4 | GO:0042407 | cristae formation(GO:0042407) |
0.7 | 2.8 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.7 | 2.8 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.7 | 4.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.7 | 2.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.7 | 4.8 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.7 | 2.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.7 | 0.7 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.7 | 4.8 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.7 | 10.9 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.7 | 0.7 | GO:1902990 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.7 | 4.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.7 | 0.7 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.7 | 1.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.7 | 1.3 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.7 | 2.7 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.7 | 1.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.7 | 2.0 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.7 | 0.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.7 | 2.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.7 | 1.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.7 | 0.7 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.7 | 0.7 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.7 | 2.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) histone mRNA catabolic process(GO:0071044) |
0.7 | 3.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.7 | 1.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.7 | 2.0 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.7 | 5.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.7 | 2.6 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.7 | 0.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.7 | 2.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.7 | 1.3 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.6 | 3.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.6 | 3.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.6 | 1.9 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.6 | 1.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.6 | 2.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.6 | 1.9 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.6 | 1.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.6 | 3.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.6 | 0.6 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.6 | 1.9 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.6 | 10.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.6 | 3.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.6 | 6.9 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.6 | 1.9 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.6 | 5.6 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.6 | 2.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.6 | 5.5 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.6 | 1.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.6 | 4.3 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.6 | 1.8 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.6 | 4.9 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.6 | 2.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.6 | 2.4 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.6 | 0.6 | GO:0060596 | mammary placode formation(GO:0060596) |
0.6 | 1.8 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.6 | 1.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.6 | 2.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.6 | 1.2 | GO:0015677 | copper ion import(GO:0015677) |
0.6 | 3.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.6 | 2.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.6 | 3.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.6 | 1.2 | GO:0036394 | amylase secretion(GO:0036394) |
0.6 | 2.4 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.6 | 1.8 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.6 | 9.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.6 | 1.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.6 | 1.8 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.6 | 2.4 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.6 | 18.9 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.6 | 2.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.6 | 2.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.6 | 1.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.6 | 1.8 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.6 | 1.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.6 | 9.9 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.6 | 2.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.6 | 1.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.6 | 1.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.6 | 1.2 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.6 | 0.6 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.6 | 1.2 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.6 | 4.0 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.6 | 2.9 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.6 | 9.1 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.6 | 2.3 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.6 | 0.6 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.6 | 2.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.6 | 1.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.6 | 1.1 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.6 | 3.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.6 | 1.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.6 | 1.7 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.6 | 9.0 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.6 | 1.7 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.6 | 1.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 0.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.6 | 5.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.6 | 2.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.6 | 2.2 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.6 | 1.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.6 | 0.6 | GO:0032202 | telomere assembly(GO:0032202) |
0.5 | 0.5 | GO:0033034 | positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.5 | 2.2 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.5 | 0.5 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.5 | 7.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.5 | 3.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 0.5 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.5 | 1.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.5 | 8.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.5 | 0.5 | GO:0051464 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.5 | 2.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.5 | 2.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 2.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.5 | 1.6 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.5 | 1.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.5 | 1.6 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.5 | 3.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.5 | 4.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.5 | 2.6 | GO:1903405 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.5 | 10.6 | GO:0010965 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.5 | 2.1 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.5 | 7.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.5 | 1.6 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.5 | 3.1 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.5 | 0.5 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.5 | 1.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.5 | 1.0 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.5 | 1.0 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.5 | 1.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.5 | 5.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.5 | 3.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.5 | 3.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.5 | 13.2 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.5 | 7.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.5 | 3.5 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.5 | 2.0 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.5 | 2.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.5 | 1.5 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.5 | 1.0 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.5 | 4.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.5 | 1.5 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.5 | 3.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 4.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.5 | 2.0 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.5 | 2.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.5 | 3.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.5 | 1.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.5 | 6.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.5 | 4.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.5 | 1.0 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.5 | 1.0 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.5 | 0.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) glyoxylate metabolic process(GO:0046487) |
0.5 | 1.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.5 | 2.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 0.5 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.5 | 1.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.5 | 1.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.5 | 1.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 6.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.5 | 5.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.5 | 5.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.5 | 2.4 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.5 | 1.4 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.5 | 1.4 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.5 | 4.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.5 | 1.9 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.5 | 3.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.5 | 1.0 | GO:0002192 | cap-independent translational initiation(GO:0002190) IRES-dependent translational initiation(GO:0002192) |
0.5 | 2.4 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 3.3 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.5 | 2.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.5 | 2.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.5 | 0.5 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.5 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.5 | 3.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.5 | 3.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.5 | 3.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.5 | 7.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.5 | 1.4 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.5 | 0.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.5 | 2.3 | GO:0015074 | DNA integration(GO:0015074) |
0.5 | 3.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.5 | 2.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.5 | 1.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 0.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.5 | 3.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.5 | 0.9 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 5.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.5 | 0.5 | GO:0051593 | response to folic acid(GO:0051593) |
0.5 | 2.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.5 | 0.9 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.5 | 1.8 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.5 | 0.9 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.5 | 0.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.5 | 1.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.4 | 14.8 | GO:0009060 | aerobic respiration(GO:0009060) |
0.4 | 1.3 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.4 | 4.0 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.4 | 1.3 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.4 | 2.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 1.3 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.4 | 1.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.4 | 4.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.4 | 3.6 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.4 | 16.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.4 | 1.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 1.8 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.4 | 2.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 0.9 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.4 | 4.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.4 | 1.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 3.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.4 | 1.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.4 | 1.8 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.4 | 2.6 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.4 | 0.9 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.4 | 1.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.4 | 5.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.4 | 1.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 2.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.4 | 0.9 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.4 | 1.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 1.3 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.4 | 1.3 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 5.6 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.4 | 0.4 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.4 | 1.7 | GO:0006415 | translational termination(GO:0006415) |
0.4 | 0.9 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.4 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 3.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.4 | 1.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 1.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 4.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.4 | 4.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.4 | 3.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.4 | 2.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 2.5 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 2.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 1.3 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.4 | 1.7 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.4 | 1.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 1.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.4 | 1.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.4 | 0.8 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.4 | 2.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.4 | 3.7 | GO:0042168 | heme metabolic process(GO:0042168) |
0.4 | 1.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.4 | 0.8 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.4 | 1.2 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.4 | 0.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.4 | 1.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.4 | 0.8 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.4 | 0.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 2.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.4 | 2.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.4 | 2.0 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.4 | 6.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.4 | 1.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 1.2 | GO:0009838 | abscission(GO:0009838) |
0.4 | 1.2 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.4 | 1.6 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.4 | 0.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.4 | 4.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.4 | 2.4 | GO:0015871 | choline transport(GO:0015871) |
0.4 | 0.4 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.4 | 0.4 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.4 | 2.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.4 | 1.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.4 | 3.2 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.4 | 0.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.4 | 3.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.4 | 3.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 0.4 | GO:1901673 | regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
0.4 | 6.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 1.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.4 | 3.5 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.4 | 1.2 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.4 | 0.8 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 2.7 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.4 | 0.8 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.4 | 1.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 1.2 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
0.4 | 6.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.4 | 5.0 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.4 | 0.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.4 | 3.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 1.5 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.4 | 0.8 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.4 | 1.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.4 | 1.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.4 | 1.9 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.4 | 3.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.4 | 1.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.4 | 1.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.4 | 0.7 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.4 | 1.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 2.6 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.4 | 0.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.4 | 2.2 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.4 | 0.7 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.4 | 1.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.4 | 3.7 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.4 | 3.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.4 | 1.8 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.4 | 1.5 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.4 | 0.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.4 | 6.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.4 | 0.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.4 | 2.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.4 | 0.4 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.4 | 1.1 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.4 | 1.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.4 | 0.7 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.4 | 3.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.4 | 1.8 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.4 | 0.4 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.4 | 0.7 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.4 | 1.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.4 | 1.1 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 2.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.4 | 2.5 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.4 | 5.3 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 1.8 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.4 | 4.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 0.4 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.4 | 2.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 1.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 0.7 | GO:0016553 | base conversion or substitution editing(GO:0016553) cytidine to uridine editing(GO:0016554) |
0.4 | 4.9 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.4 | 1.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 4.9 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.4 | 2.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 2.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.3 | 0.3 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 7.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.3 | 0.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.3 | 2.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.3 | 1.4 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.3 | 12.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 0.7 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.3 | 1.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.3 | 2.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 1.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 1.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 0.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.3 | 0.7 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.3 | 1.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 2.0 | GO:0043486 | histone exchange(GO:0043486) |
0.3 | 2.7 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.3 | 15.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 2.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 5.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.3 | 1.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.3 | 1.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 3.3 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.3 | 1.7 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 1.0 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.3 | 1.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.3 | 1.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 0.7 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.3 | 2.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 0.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.3 | 8.8 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.3 | 0.3 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 1.9 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.3 | 1.9 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 1.0 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.3 | 7.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 0.6 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.3 | 1.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 1.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 1.0 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.3 | 1.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.3 | 0.3 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.3 | 0.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 0.3 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.3 | 1.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.3 | 1.0 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.3 | 0.3 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 0.3 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.3 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.3 | 0.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.3 | 0.3 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.3 | 0.9 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 0.6 | GO:0070295 | renal water absorption(GO:0070295) |
0.3 | 0.6 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.3 | 2.8 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 0.9 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 1.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 1.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 4.0 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.3 | 2.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.3 | 1.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.3 | 10.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 0.6 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.3 | 0.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 0.9 | GO:0060283 | negative regulation of oocyte development(GO:0060283) regulation of oocyte maturation(GO:1900193) negative regulation of oocyte maturation(GO:1900194) |
0.3 | 1.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 0.3 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.3 | 1.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 5.5 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.3 | 0.3 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.3 | 0.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 1.2 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 0.9 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.3 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 0.6 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 0.3 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.3 | 5.4 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.3 | 2.1 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.3 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 0.3 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.3 | 0.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 1.5 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 0.9 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.6 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.3 | 0.3 | GO:1901563 | response to camptothecin(GO:1901563) |
0.3 | 0.6 | GO:0002581 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.3 | 1.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.3 | 0.6 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 1.2 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 0.6 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.3 | 0.6 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.3 | 1.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.3 | 0.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 0.6 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.3 | 0.3 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.3 | 1.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.3 | 1.2 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.3 | 0.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 0.6 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.3 | 0.6 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.3 | 0.3 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.3 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.8 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.3 | 2.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 1.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.3 | 0.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.3 | 1.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 0.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.3 | 0.6 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.3 | 1.4 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.3 | 0.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 0.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 0.6 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.3 | 0.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.3 | 1.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 0.3 | GO:1901656 | glycoside transport(GO:1901656) |
0.3 | 0.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 0.3 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.3 | 1.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.3 | 0.3 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.3 | 0.5 | GO:0050779 | RNA destabilization(GO:0050779) |
0.3 | 1.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 3.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.3 | 1.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 0.5 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 2.7 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.3 | 0.8 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.3 | 0.5 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.3 | 2.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 0.5 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.3 | 0.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 | 2.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 0.3 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.3 | 0.5 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.3 | 0.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 2.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.3 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 0.5 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.3 | 1.6 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 0.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 0.8 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.3 | 3.9 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.3 | 1.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.8 | GO:0002576 | platelet degranulation(GO:0002576) |
0.3 | 0.5 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.3 | 0.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.3 | 0.8 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.3 | 0.3 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 0.5 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 0.5 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 0.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.3 | 0.5 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 0.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 1.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 0.5 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 1.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.3 | 1.3 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.3 | 1.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.3 | 0.8 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 0.8 | GO:2000348 | CD40 signaling pathway(GO:0023035) regulation of CD40 signaling pathway(GO:2000348) |
0.3 | 0.5 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.3 | 1.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.3 | 0.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.3 | 5.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.3 | 11.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.3 | 1.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.3 | 0.8 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.5 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.2 | 0.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.2 | 1.7 | GO:0051304 | chromosome separation(GO:0051304) |
0.2 | 0.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 1.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 1.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 5.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.5 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.2 | 0.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 1.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.2 | 0.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 2.9 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 0.2 | GO:0052204 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.2 | 0.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 0.7 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.2 | 0.2 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.2 | 0.7 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.2 | 0.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 2.4 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.2 | 0.5 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.2 | 1.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 | 14.1 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.2 | 0.2 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.2 | 0.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.5 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 0.2 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 0.5 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 0.7 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 2.8 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.2 | 0.7 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.2 | 0.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 1.6 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 1.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 1.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 0.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.2 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.2 | 0.7 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 1.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.5 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 1.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.4 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 1.8 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.2 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 0.9 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 0.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 0.9 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.2 | 3.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.2 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.2 | 0.4 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 0.4 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 1.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 2.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.2 | 1.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 1.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.2 | 3.4 | GO:0007041 | lysosomal transport(GO:0007041) |
0.2 | 1.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 0.9 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 17.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 1.7 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 0.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 4.0 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 4.6 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.2 | 0.4 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 4.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 0.4 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.6 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.2 | 0.4 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.2 | 0.2 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.2 | 1.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 1.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 2.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 35.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 1.6 | GO:0072666 | protein targeting to vacuole(GO:0006623) establishment of protein localization to vacuole(GO:0072666) |
0.2 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 0.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 1.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 5.5 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.2 | 3.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.8 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 2.4 | GO:0070542 | response to fatty acid(GO:0070542) |
0.2 | 0.2 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 1.8 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 1.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 1.4 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 1.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 0.8 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.2 | 0.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.2 | 0.2 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.2 | 1.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 5.0 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 0.6 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 0.4 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.2 | 1.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 3.8 | GO:0022900 | electron transport chain(GO:0022900) |
0.2 | 1.0 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.2 | 3.1 | GO:0016573 | histone acetylation(GO:0016573) |
0.2 | 6.7 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.2 | 2.9 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.2 | 0.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 0.4 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.2 | 1.7 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.6 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.2 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.2 | 0.4 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.2 | 0.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 5.6 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 0.6 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 0.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.2 | 0.2 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 2.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 0.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.2 | 0.7 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.2 | 1.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 0.5 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.2 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.2 | 0.7 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 0.2 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.5 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 3.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.4 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.2 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 1.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 6.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 5.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 0.2 | GO:0042402 | cellular biogenic amine catabolic process(GO:0042402) |
0.2 | 0.2 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.2 | 5.0 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.2 | 3.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.2 | 0.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 0.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 1.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.2 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.2 | 1.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 0.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.2 | 0.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.2 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.2 | 1.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 2.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 2.5 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 0.5 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 0.3 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 1.0 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.3 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 0.6 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 0.6 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.6 | GO:0001774 | microglial cell activation(GO:0001774) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.3 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 0.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 1.0 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 1.6 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.2 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.2 | 0.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.2 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 0.8 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 0.5 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 0.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.9 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.2 | 0.2 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) |
0.2 | 0.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 0.2 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.2 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 0.5 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.2 | 2.6 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.2 | 1.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.3 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.2 | 0.9 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.2 | 0.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 3.0 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.2 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.3 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.6 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.1 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.1 | 0.3 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 0.3 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 1.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.7 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 2.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.1 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.1 | 0.7 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.1 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.1 | 1.1 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.6 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.6 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.1 | 1.0 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 1.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 1.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.6 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 1.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.1 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.1 | 1.4 | GO:0044743 | intracellular protein transmembrane import(GO:0044743) |
0.1 | 1.0 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.4 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 1.1 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.1 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.1 | 0.7 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 1.5 | GO:0032608 | interferon-beta production(GO:0032608) |
0.1 | 0.5 | GO:0034397 | telomere localization(GO:0034397) |
0.1 | 0.3 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.1 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.1 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.3 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.1 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 0.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.6 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 4.9 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.8 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.3 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.1 | 0.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 0.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.4 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.1 | 0.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.8 | GO:0098581 | detection of external biotic stimulus(GO:0098581) |
0.1 | 0.1 | GO:0007619 | courtship behavior(GO:0007619) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.8 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 1.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 1.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 15.5 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.1 | 4.8 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.1 | 1.2 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.6 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.5 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.1 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 1.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.9 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.1 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.7 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.7 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.5 | GO:0009435 | NAD biosynthetic process(GO:0009435) nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.1 | 0.3 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.2 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
0.1 | 0.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.1 | 0.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.3 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.3 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.4 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 2.5 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 1.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.3 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.1 | 0.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.4 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 1.9 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.8 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 3.9 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.1 | 4.4 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.8 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.1 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 1.1 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 4.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.2 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.4 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 0.1 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.2 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.2 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.1 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.9 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 2.3 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 7.1 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.1 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 1.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.4 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.2 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.2 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 2.9 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.1 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.1 | 0.4 | GO:0022618 | ribonucleoprotein complex assembly(GO:0022618) |
0.1 | 0.5 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.3 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.1 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 0.2 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.1 | 0.3 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.2 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 3.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.2 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.1 | 1.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.3 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.2 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.3 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 0.1 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.2 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.7 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.6 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.2 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.1 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.4 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.2 | GO:0002504 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 1.9 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.1 | 0.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.3 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.2 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.2 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.1 | 0.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.6 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.1 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.4 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 | 0.1 | GO:0060339 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.4 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.7 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 0.8 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.2 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.1 | GO:0002739 | regulation of cytokine secretion involved in immune response(GO:0002739) |
0.1 | 0.7 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.1 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.1 | 0.5 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.1 | 0.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.1 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.1 | 0.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 1.2 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.3 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.1 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.1 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.1 | 0.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.2 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.1 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.1 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.1 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.1 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.1 | 0.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 0.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.2 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.1 | 0.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.1 | GO:0032692 | negative regulation of interleukin-1 production(GO:0032692) |
0.1 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.3 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.5 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.5 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.1 | 0.8 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.0 | 0.0 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.0 | 0.1 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.9 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.0 | 0.0 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) regulation of cell proliferation in bone marrow(GO:0071863) positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.0 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.0 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.0 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.9 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.1 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.0 | 0.8 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.0 | GO:0045913 | positive regulation of carbohydrate metabolic process(GO:0045913) |
0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.0 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.0 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.3 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.0 | 0.1 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.0 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.0 | 0.1 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.0 | 0.2 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.0 | 0.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.6 | GO:1900449 | regulation of neurotransmitter receptor activity(GO:0099601) regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.0 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.0 | 0.0 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.1 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.0 | 0.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.0 | 0.0 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.0 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 1.4 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 0.2 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.6 | GO:0044264 | cellular polysaccharide metabolic process(GO:0044264) |
0.0 | 0.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.0 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.0 | 0.0 | GO:0043255 | regulation of carbohydrate biosynthetic process(GO:0043255) |
0.0 | 0.1 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.0 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.0 | 0.2 | GO:0048753 | pigment granule organization(GO:0048753) |
0.0 | 0.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.1 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.0 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.0 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.1 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.0 | 0.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.0 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.0 | 0.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.1 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 0.0 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.0 | 0.1 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.1 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:1903299 | regulation of hexokinase activity(GO:1903299) |
0.0 | 0.0 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.0 | 0.1 | GO:0015918 | sterol transport(GO:0015918) |
0.0 | 0.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.7 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.0 | 0.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.2 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.0 | 0.0 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.0 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.0 | 0.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.0 | 0.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 15.7 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.0 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.0 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.1 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.0 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.0 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.1 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 26.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
4.3 | 12.8 | GO:0097413 | Lewy body(GO:0097413) |
3.7 | 11.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.5 | 17.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
2.4 | 2.4 | GO:0030008 | TRAPP complex(GO:0030008) |
2.3 | 7.0 | GO:0097451 | glial limiting end-foot(GO:0097451) |
2.3 | 11.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.2 | 6.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
2.1 | 8.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.9 | 11.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.8 | 7.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.7 | 12.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.7 | 13.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.7 | 10.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.6 | 4.7 | GO:0005771 | multivesicular body(GO:0005771) |
1.5 | 5.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.4 | 10.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.4 | 4.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.4 | 5.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.4 | 5.7 | GO:0000322 | storage vacuole(GO:0000322) |
1.4 | 7.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.4 | 4.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.4 | 4.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.3 | 5.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.3 | 1.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.3 | 1.3 | GO:0016939 | kinesin II complex(GO:0016939) |
1.3 | 7.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.2 | 7.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.2 | 4.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.2 | 8.1 | GO:0042382 | paraspeckles(GO:0042382) |
1.2 | 7.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.2 | 3.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.1 | 3.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.1 | 1.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
1.1 | 5.4 | GO:0061617 | MICOS complex(GO:0061617) |
1.1 | 3.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.1 | 3.2 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.0 | 10.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
1.0 | 4.2 | GO:0033269 | internode region of axon(GO:0033269) |
1.0 | 4.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.0 | 6.1 | GO:0071986 | Ragulator complex(GO:0071986) |
1.0 | 6.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.0 | 4.0 | GO:0097433 | dense body(GO:0097433) |
1.0 | 2.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.0 | 2.0 | GO:1903349 | extrinsic component of omegasome membrane(GO:0097629) omegasome membrane(GO:1903349) |
1.0 | 4.0 | GO:0000125 | PCAF complex(GO:0000125) |
1.0 | 3.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.0 | 1.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.0 | 9.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.0 | 2.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.0 | 10.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.0 | 2.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.0 | 2.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.9 | 10.4 | GO:0042581 | specific granule(GO:0042581) |
0.9 | 7.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.9 | 3.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.9 | 4.4 | GO:0089701 | U2AF(GO:0089701) |
0.9 | 27.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.9 | 20.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.9 | 20.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.8 | 3.3 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 2.5 | GO:0031417 | NatC complex(GO:0031417) |
0.8 | 1.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.8 | 7.4 | GO:0051286 | cell tip(GO:0051286) |
0.8 | 4.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.8 | 6.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.8 | 7.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.8 | 0.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.8 | 2.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.8 | 5.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.8 | 7.9 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.8 | 3.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.8 | 3.9 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 11.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.8 | 16.3 | GO:0045120 | pronucleus(GO:0045120) |
0.8 | 4.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.8 | 6.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.8 | 1.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.8 | 2.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.8 | 0.8 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.8 | 3.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.8 | 44.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.7 | 2.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.7 | 2.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.7 | 3.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.7 | 5.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.7 | 25.8 | GO:0016592 | mediator complex(GO:0016592) |
0.7 | 13.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.7 | 5.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.7 | 2.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.7 | 2.2 | GO:0016589 | NURF complex(GO:0016589) |
0.7 | 10.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.7 | 9.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.7 | 8.5 | GO:0036038 | MKS complex(GO:0036038) |
0.7 | 1.4 | GO:0071203 | WASH complex(GO:0071203) |
0.7 | 9.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.7 | 2.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.7 | 12.9 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.7 | 2.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.7 | 2.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.7 | 4.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.7 | 2.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.7 | 4.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 2.6 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.7 | 3.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.7 | 7.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.7 | 2.0 | GO:0000805 | X chromosome(GO:0000805) |
0.6 | 11.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.6 | 5.2 | GO:0043034 | costamere(GO:0043034) |
0.6 | 28.8 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.6 | 19.8 | GO:0005776 | autophagosome(GO:0005776) |
0.6 | 24.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.6 | 12.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.6 | 1.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.6 | 6.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.6 | 7.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.6 | 1.9 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.6 | 1.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 2.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.6 | 3.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.6 | 1.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.6 | 2.4 | GO:0000796 | condensin complex(GO:0000796) |
0.6 | 1.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.6 | 1.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.6 | 7.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.6 | 8.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.6 | 4.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.6 | 8.1 | GO:0071565 | nBAF complex(GO:0071565) |
0.6 | 24.2 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.6 | 4.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.6 | 1.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 2.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 7.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.6 | 5.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.6 | 1.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.6 | 3.9 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.6 | 3.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.5 | 3.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.5 | 19.0 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.5 | 3.8 | GO:0090544 | BAF-type complex(GO:0090544) |
0.5 | 3.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 2.7 | GO:0034709 | methylosome(GO:0034709) |
0.5 | 2.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.5 | 1.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 1.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 4.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.5 | 3.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.5 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.5 | 2.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 4.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.5 | 1.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 2.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.5 | 3.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 9.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.5 | 0.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.5 | 10.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.5 | 2.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.5 | 3.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.5 | 5.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.5 | 7.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.5 | 4.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.5 | 7.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.5 | 3.0 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.5 | 4.4 | GO:0097346 | INO80-type complex(GO:0097346) |
0.5 | 1.0 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.5 | 2.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.5 | 8.3 | GO:0030904 | retromer complex(GO:0030904) |
0.5 | 25.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.5 | 5.3 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 4.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.5 | 4.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.5 | 4.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.5 | 26.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.5 | 1.9 | GO:0001739 | sex chromatin(GO:0001739) |
0.5 | 23.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.5 | 5.6 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.5 | 1.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.5 | 3.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.5 | 7.4 | GO:0030496 | midbody(GO:0030496) |
0.5 | 5.5 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.5 | 3.6 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.5 | 5.4 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.5 | 1.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.4 | 2.2 | GO:0005818 | aster(GO:0005818) |
0.4 | 4.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.4 | 1.7 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.4 | 2.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.4 | 1.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 6.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.4 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 2.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 1.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 2.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.4 | 2.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 8.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 2.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.4 | 2.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 3.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.4 | 0.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 0.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.4 | 2.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 10.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.4 | 1.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 13.9 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.4 | 2.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.4 | 1.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.4 | 1.5 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.4 | 3.4 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.4 | 36.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.4 | 1.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.4 | 3.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 1.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 3.9 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.4 | 3.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.4 | 7.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 6.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 0.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.4 | 1.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 0.4 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.3 | 4.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 1.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 3.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 1.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 10.1 | GO:0005657 | replication fork(GO:0005657) |
0.3 | 4.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 3.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 1.0 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.3 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 1.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 2.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.3 | 13.7 | GO:0000776 | kinetochore(GO:0000776) |
0.3 | 1.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 3.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 2.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 1.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 7.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 3.2 | GO:0034399 | nuclear periphery(GO:0034399) |
0.3 | 4.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 0.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 1.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 1.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 2.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 4.6 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.3 | 5.2 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 1.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 32.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 0.6 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.3 | 1.2 | GO:0070695 | FHF complex(GO:0070695) |
0.3 | 1.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 2.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 3.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 7.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 4.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 0.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 2.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 4.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 12.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 0.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 23.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 19.1 | GO:0044450 | microtubule organizing center part(GO:0044450) |
0.3 | 0.8 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 63.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.3 | 5.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 1.3 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 2.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 2.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 11.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.3 | 14.5 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.3 | 13.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.3 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 0.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 0.8 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 3.6 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.3 | 7.7 | GO:0036064 | ciliary basal body(GO:0036064) |
0.3 | 0.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 15.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 5.5 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.3 | 1.0 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 5.8 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 1.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 8.7 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 6.2 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.2 | 12.3 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 0.7 | GO:0002177 | manchette(GO:0002177) |
0.2 | 3.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.5 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 1.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 2.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 1.0 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 7.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 0.7 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.2 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.2 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.2 | 2.3 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.2 | 1.1 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.2 | 0.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 45.4 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 0.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 0.7 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 1.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 21.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 2.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.6 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 86.6 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 0.8 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.2 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 196.1 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 1.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 1.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 2.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.2 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.2 | 0.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 1.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 1.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 3.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 17.2 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 5.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 11.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 4.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 1.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 4.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 1.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 5.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 1.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.2 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.2 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 4.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.2 | 29.5 | GO:0044431 | Golgi apparatus part(GO:0044431) |
0.2 | 4.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 1.9 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 127.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 1.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 3.3 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 74.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.3 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 1.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.1 | 11.3 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 11.8 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 17.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.1 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.1 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 4.5 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 1.1 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 1.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 1.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 43.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.1 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 5.7 | GO:1990234 | transferase complex(GO:1990234) |
0.1 | 10.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 2.3 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 1.2 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 5.7 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.5 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.0 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.4 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.0 | GO:0036128 | CatSper complex(GO:0036128) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
3.5 | 10.6 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
3.3 | 10.0 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
3.3 | 9.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.1 | 9.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
2.9 | 11.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
2.3 | 9.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.3 | 6.9 | GO:0019961 | interferon binding(GO:0019961) |
2.1 | 8.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.9 | 5.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.9 | 5.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.9 | 5.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.9 | 7.6 | GO:0043515 | kinetochore binding(GO:0043515) |
1.9 | 15.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.9 | 14.9 | GO:0039706 | co-receptor binding(GO:0039706) |
1.8 | 12.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.8 | 7.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.8 | 8.9 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.8 | 19.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.7 | 6.8 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.7 | 6.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.7 | 1.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.6 | 8.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.6 | 4.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.5 | 4.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.5 | 9.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.5 | 6.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.5 | 4.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.5 | 12.0 | GO:0008430 | selenium binding(GO:0008430) |
1.5 | 5.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.5 | 4.4 | GO:1990188 | euchromatin binding(GO:1990188) |
1.5 | 4.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.4 | 4.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.4 | 5.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.4 | 1.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
1.4 | 1.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.4 | 1.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
1.4 | 6.8 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.3 | 4.0 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.3 | 6.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.3 | 3.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.3 | 2.6 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.3 | 3.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.3 | 5.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.3 | 3.8 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
1.3 | 5.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.3 | 3.8 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.3 | 5.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
1.2 | 11.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.2 | 3.6 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.2 | 5.9 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.2 | 4.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.1 | 10.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.1 | 9.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.1 | 3.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.1 | 3.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.1 | 4.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.1 | 26.4 | GO:0030552 | cAMP binding(GO:0030552) |
1.1 | 3.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.1 | 6.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.1 | 5.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.1 | 3.2 | GO:0004064 | arylesterase activity(GO:0004064) |
1.1 | 9.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.1 | 4.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.1 | 4.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.0 | 4.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.0 | 1.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.0 | 5.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.0 | 10.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.0 | 3.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.0 | 3.0 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.0 | 6.9 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.0 | 2.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.0 | 3.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.0 | 7.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.0 | 2.9 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.0 | 1.9 | GO:0043842 | Kdo transferase activity(GO:0043842) |
1.0 | 6.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.0 | 2.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.9 | 4.7 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.9 | 5.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.9 | 3.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.9 | 4.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.9 | 2.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.9 | 19.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.9 | 13.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.9 | 7.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.9 | 31.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.9 | 4.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.9 | 2.7 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.9 | 4.4 | GO:0097617 | annealing activity(GO:0097617) |
0.9 | 7.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.9 | 2.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.9 | 7.9 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.9 | 7.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.9 | 5.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.9 | 2.6 | GO:0030519 | snoRNP binding(GO:0030519) |
0.9 | 2.6 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.9 | 18.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.9 | 2.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.8 | 2.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.8 | 3.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.8 | 5.0 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.8 | 0.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.8 | 41.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.8 | 2.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.8 | 1.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.8 | 8.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.8 | 0.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.8 | 2.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.8 | 5.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.8 | 11.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.8 | 7.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.8 | 3.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.8 | 2.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.8 | 0.8 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.8 | 1.6 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.8 | 2.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.8 | 11.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.8 | 3.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.8 | 2.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.8 | 9.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.8 | 2.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.8 | 1.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.8 | 2.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.8 | 1.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.8 | 2.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.7 | 6.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.7 | 3.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.7 | 5.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.7 | 7.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.7 | 2.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.7 | 13.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.7 | 2.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.7 | 2.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.7 | 2.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 14.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.7 | 2.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 1.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.7 | 3.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.7 | 2.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.7 | 2.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.7 | 3.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.7 | 2.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.7 | 3.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.7 | 5.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.7 | 12.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.7 | 2.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.7 | 2.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.7 | 2.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.7 | 19.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.7 | 6.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.7 | 4.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.7 | 0.7 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.7 | 0.7 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.7 | 4.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.7 | 2.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.7 | 2.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 2.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.7 | 2.7 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.7 | 4.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.7 | 6.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.7 | 6.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.7 | 1.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.7 | 2.6 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.7 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.7 | 2.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.7 | 0.7 | GO:0002054 | nucleobase binding(GO:0002054) |
0.7 | 3.9 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.6 | 0.6 | GO:0003896 | DNA primase activity(GO:0003896) |
0.6 | 3.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.6 | 4.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.6 | 15.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.6 | 1.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.6 | 1.9 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.6 | 1.3 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.6 | 6.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 2.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.6 | 5.0 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.6 | 0.6 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.6 | 13.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.6 | 1.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.6 | 1.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 1.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 3.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.6 | 1.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 1.8 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.6 | 5.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.6 | 8.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.6 | 5.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.6 | 2.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.6 | 4.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 4.2 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.6 | 1.8 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.6 | 3.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.6 | 3.6 | GO:0000339 | RNA cap binding(GO:0000339) |
0.6 | 11.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 1.8 | GO:0070728 | leucine binding(GO:0070728) |
0.6 | 1.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.6 | 1.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.6 | 3.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.6 | 2.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.6 | 4.0 | GO:0046790 | virion binding(GO:0046790) |
0.6 | 2.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.6 | 10.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.6 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.6 | 17.9 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.6 | 2.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.6 | 4.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.6 | 2.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 3.3 | GO:0015321 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.5 | 2.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.5 | 1.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 15.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.5 | 2.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.5 | 4.3 | GO:0070513 | death domain binding(GO:0070513) |
0.5 | 1.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.5 | 2.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.5 | 1.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 3.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.5 | 6.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.5 | 2.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 1.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.5 | 5.7 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.5 | 1.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 1.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 13.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.5 | 2.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.5 | 10.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.5 | 2.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.5 | 2.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.5 | 14.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.5 | 6.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.5 | 9.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.5 | 6.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 0.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.5 | 0.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 2.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 2.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 2.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.5 | 9.9 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.5 | 1.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 1.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 10.3 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.5 | 11.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.5 | 1.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.5 | 3.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.5 | 1.4 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.5 | 1.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.5 | 2.4 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.5 | 1.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.5 | 3.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.5 | 5.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.5 | 0.9 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.5 | 2.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 1.9 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.5 | 2.3 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.5 | 1.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.5 | 1.4 | GO:0051870 | methotrexate binding(GO:0051870) |
0.5 | 0.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.5 | 7.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.5 | 2.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.5 | 13.1 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.5 | 1.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.5 | 6.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.5 | 0.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.4 | 9.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 5.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.4 | 42.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 5.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.4 | 1.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 2.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.4 | 1.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 4.0 | GO:0042469 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 4.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 3.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.4 | 0.9 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.4 | 3.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.4 | 1.3 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 1.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 8.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 3.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 1.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 3.5 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.4 | 0.9 | GO:0035877 | death effector domain binding(GO:0035877) |
0.4 | 15.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 4.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.4 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.4 | 2.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 3.8 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.4 | 2.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.4 | 2.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.4 | 0.4 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.4 | 1.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 2.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 1.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 5.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.4 | 0.4 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.4 | 0.8 | GO:0004103 | choline kinase activity(GO:0004103) |
0.4 | 1.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 5.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 0.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 1.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.4 | 4.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.4 | 1.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.4 | 3.2 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 1.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.4 | 1.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 0.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 1.6 | GO:0035173 | histone kinase activity(GO:0035173) |
0.4 | 1.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.4 | 2.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 1.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.4 | 1.9 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 1.9 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 1.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.4 | 0.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 0.8 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.4 | 1.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.4 | 3.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.4 | 0.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 1.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 14.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.4 | 1.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 0.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 1.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.4 | 1.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 3.7 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.4 | 1.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.4 | 2.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 5.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 1.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.4 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 1.1 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 12.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.4 | 1.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.4 | 1.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 1.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 3.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 0.7 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 26.5 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.3 | 2.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 19.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.3 | 6.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.3 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 1.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 1.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 4.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 3.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 6.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 3.8 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.3 | 0.3 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
0.3 | 3.7 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.3 | 2.0 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 3.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 48.7 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.3 | 0.7 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 1.0 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.3 | 2.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 1.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 1.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 1.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.3 | 1.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 12.5 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.3 | 0.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 1.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 0.3 | GO:0019825 | oxygen binding(GO:0019825) |
0.3 | 4.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 1.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 1.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 1.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 3.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 1.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 2.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 1.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 33.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.3 | 1.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 1.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 1.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 0.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 3.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 0.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 3.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 12.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.3 | 0.9 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.3 | 1.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 1.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 1.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 4.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 12.4 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 2.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 1.2 | GO:0052758 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.3 | 1.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 0.6 | GO:0000182 | rDNA binding(GO:0000182) |
0.3 | 0.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 12.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.3 | 0.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 8.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 1.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 0.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 0.6 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 1.5 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 0.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 0.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.3 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 1.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.3 | 3.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 1.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 1.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 2.6 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 0.8 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 0.6 | GO:0015928 | fucosidase activity(GO:0015928) |
0.3 | 0.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.3 | 13.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.3 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 0.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.3 | 4.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 7.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.3 | 2.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 1.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 10.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 3.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 5.4 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.3 | 0.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 12.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 1.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 4.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 1.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 1.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.3 | 0.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 0.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 1.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 5.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 0.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 2.8 | GO:0090484 | drug transporter activity(GO:0090484) |
0.3 | 1.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 0.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 2.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.7 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 16.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.2 | 1.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 11.9 | GO:0019209 | kinase activator activity(GO:0019209) |
0.2 | 3.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 3.6 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 2.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 1.7 | GO:0009055 | electron carrier activity(GO:0009055) |
0.2 | 0.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 38.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 6.1 | GO:0051117 | ATPase binding(GO:0051117) |
0.2 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 13.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 1.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 6.2 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 0.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 0.5 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 5.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 2.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 1.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.7 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.2 | 4.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 1.6 | GO:0070990 | snRNP binding(GO:0070990) |
0.2 | 2.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 1.6 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 0.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 1.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 31.3 | GO:0048037 | cofactor binding(GO:0048037) |
0.2 | 5.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 145.4 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 2.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 1.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 2.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 3.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 2.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.8 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 1.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 9.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.6 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 1.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 1.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.6 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 0.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.2 | 8.8 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.2 | 0.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 0.4 | GO:0018503 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 1.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 1.0 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 0.2 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.2 | 0.2 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 1.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 5.2 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 1.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 0.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 1.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.5 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 1.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.2 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.2 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 0.7 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 13.8 | GO:0051020 | GTPase binding(GO:0051020) |
0.2 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 1.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 1.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 4.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 0.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.2 | 1.3 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 0.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 0.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 0.6 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 2.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.5 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.2 | 2.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 4.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 0.3 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.6 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.7 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 1.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.7 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 2.8 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 2.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 2.8 | GO:1901476 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.1 | 1.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 2.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.6 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.4 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.1 | 2.5 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
0.1 | 3.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.4 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 5.8 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 2.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 2.4 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 0.3 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.7 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 1.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 2.5 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.5 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.4 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.1 | 0.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 12.6 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 1.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.6 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.3 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 4.5 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 4.0 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 3.8 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.1 | 0.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 2.0 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 1.9 | GO:0016791 | phosphatase activity(GO:0016791) |
0.1 | 0.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 6.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 1.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.1 | GO:0034811 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 1.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 3.1 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.1 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.5 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.1 | 0.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 10.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 1.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.7 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 1.4 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 11.7 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.1 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 1.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 1.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.2 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.0 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.9 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 1.1 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.0 | 0.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.8 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 3.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 6.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.4 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.0 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.5 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 1.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 3.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 2.0 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 2.3 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.0 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.4 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.1 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 21.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.0 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.0 | 0.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.0 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 14.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.1 | 22.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.9 | 2.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.9 | 12.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.8 | 15.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.8 | 21.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.8 | 10.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.7 | 23.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.7 | 11.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 24.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.6 | 9.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 13.7 | PID MYC PATHWAY | C-MYC pathway |
0.6 | 1.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.6 | 2.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 1.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 24.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.5 | 5.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 10.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.5 | 10.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.5 | 6.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 13.8 | PID FOXO PATHWAY | FoxO family signaling |
0.5 | 4.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 7.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 4.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.5 | 22.1 | PID E2F PATHWAY | E2F transcription factor network |
0.5 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 3.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 11.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 1.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 3.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 8.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 4.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.4 | 2.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.4 | 10.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 16.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.4 | 19.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 5.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 10.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 6.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 13.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 11.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 7.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 10.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 13.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 2.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 3.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 3.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 8.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 1.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 1.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 3.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 2.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 8.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 11.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 1.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 4.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 14.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 6.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 3.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 0.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 2.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 1.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 4.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 1.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 0.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 0.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 4.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 2.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 3.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 2.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 1.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 1.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 1.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 2.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 2.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 1.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 2.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 2.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 1.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 2.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 4.0 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 2.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 2.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 1.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 2.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 2.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 4.8 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
2.1 | 20.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.8 | 25.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.8 | 17.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.5 | 1.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
1.3 | 18.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.2 | 6.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.2 | 11.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.2 | 4.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
1.0 | 52.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.0 | 11.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.9 | 1.9 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.9 | 8.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.9 | 11.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.8 | 13.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.8 | 10.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.8 | 1.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.8 | 18.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.8 | 6.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.8 | 8.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.8 | 2.3 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.7 | 12.6 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.7 | 3.7 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.7 | 15.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.7 | 47.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.7 | 2.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.7 | 7.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.7 | 5.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.7 | 18.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.7 | 0.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.7 | 4.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.7 | 1.4 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.7 | 12.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.7 | 12.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.7 | 9.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.7 | 10.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.7 | 20.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 9.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.6 | 6.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.6 | 12.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.6 | 3.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.6 | 8.5 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.6 | 13.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.6 | 7.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.6 | 3.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.6 | 5.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.6 | 9.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.6 | 4.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 2.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.6 | 4.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.6 | 2.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.6 | 43.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.6 | 2.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.6 | 6.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.6 | 6.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.5 | 8.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.5 | 4.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.5 | 2.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.5 | 2.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.5 | 2.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.5 | 3.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.5 | 7.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 7.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.5 | 4.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.5 | 0.5 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.5 | 3.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.5 | 5.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.5 | 3.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.5 | 7.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.5 | 14.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 5.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 4.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.5 | 4.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.5 | 3.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.5 | 4.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 6.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.5 | 9.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 7.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 5.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 29.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.4 | 10.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.4 | 9.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 8.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 1.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 5.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 0.8 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.4 | 29.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.4 | 4.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 3.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.4 | 7.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.4 | 2.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.4 | 5.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.4 | 1.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.4 | 6.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 8.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.4 | 4.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 3.0 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.4 | 1.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.4 | 3.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.4 | 9.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 9.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 4.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 5.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.4 | 2.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 3.9 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.4 | 1.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.4 | 13.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.4 | 12.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 9.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 5.9 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.3 | 5.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 2.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 9.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 2.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 3.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 2.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 1.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 1.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 3.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 3.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 6.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 9.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 14.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 0.6 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.3 | 3.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.3 | 2.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.3 | 4.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 4.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 3.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 5.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 2.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 3.0 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.3 | 7.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 5.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 2.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 6.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 1.1 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.3 | 23.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 2.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 5.4 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.3 | 2.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 2.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.3 | 1.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 1.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 2.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 3.3 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.2 | 2.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 0.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 0.2 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.2 | 4.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 1.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 3.3 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 1.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 0.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 0.4 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 1.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 1.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 20.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 1.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 5.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 3.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 2.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 4.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 0.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 0.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 3.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 1.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 1.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.0 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 4.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 3.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 4.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 6.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 3.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 1.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 2.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 1.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 6.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 1.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 2.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 3.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.2 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.9 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 1.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.3 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.1 | 0.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.6 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.3 | REACTOME CELL CYCLE MITOTIC | Genes involved in Cell Cycle, Mitotic |
0.0 | 0.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |